Consequently, HDAC6 is being explored as a therapeutic target for cancers and various neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS) [13,14]. This evidence concerns the gene HDAC6 and Huntington disease.